Giananthony Rizzo[email protected]Nuclear MedicineIs the U.S. due for a shortage of SPECT tracers? Part 2In the second part of our series on the coming shortage of SPECT radiopharmaceuticals, Giananthony Rizzo of Decision Resources Group examines other factors in the U.S. healthcare industry that could affect isotope prices in the future.November 17, 2016Nuclear MedicineIs the U.S. due for a shortage of SPECT tracers? Part 1A perfect storm is brewing in the global SPECT market that could see the prices of radiopharmaceuticals skyrocket over the next five years. A number of factors are coalescing that could lead to a shortage of SPECT tracers for years to come, according to this article by Giananthony Rizzo of Decision Resources Group.November 16, 2016Page 1 of 1Top StoriesBreastNME breast lesions have high malignancy rate on MRI-guided biopsyBiopsies from women with a known ipsilateral malignancy have a higher frequency of breast cancer.Womens ImagingMany women interested in AI-based risk assessment for breast cancerCTCT 5-star quality rating system supports optimizationUltrasoundREAD-DVT model performs well in finding DVT from ultrasound reportsSponsor ContentNominations Are Open — 2026 Minnies
